News

More than 35 lectures across seven topics, plus a keynote address, will be featured during the meeting

Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal

Special programming for young ophthalmologists will be hosted in the YO lounge

This year’s multi-specialty programme features the SOE Leadership Development Programme (EuLDP), the International Society of Ocular Trauma (ISOT), European University Professors of Ophthalmology (EUPO) and more

Brazilian ANVISA has granted marketing authorisation for FYB201 (Ranivisio), a biosimilar to Lucentis.

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

Long-term benefits and vision preservation using an extended macular vision IOL

Insights from a genome-wide association study identify novel genetic loci

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors

The therapy planning support tool has been trained on thousands of patient cases from more than 200 retina centres throughout Europe

The Optegra platform currently operates in the Czech Republic, the Netherlands, Poland, Slovakia and the United Kingdom

Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study

Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States

The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia

The biomarkers are especially crucial for patients with lupus nephritis

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.

The LuxLife full range of vision intraocular lens is available in a range of cylinders spanning from +0.75D to +6.00D.

Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK

Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.

Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.

Research findings compare the rotational stability of a monofocal plus toric IOL with traditional toric lenses

Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting